An anticancer drug blunted atherosclerosis progression — and even made plaques shrink — in a mouse model of the disease, opening new opportunities for preventing and treating this leading cause of death.

Vanderbilt University Medical Center has been awarded a seven-year, $5 million award to conduct food allergy research, joining nine other institutions as part of the Consortium for Food Allergy Research.

A new tool to identify infants most at risk for severe respiratory syncytial virus (RSV) illness could aid pediatricians in prioritizing children under 1 to receive a preventive medication before RSV season (October-April).

A multicenter study led by Vanderbilt University Medical Center and Lipscomb University College of Pharmacy in Nashville has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death.

Researchers at Vanderbilt University Medical Center have demonstrated the potential for large language models like ChatGPT to help generate electronic health record phenotyping algorithms, a critical but time-consuming task in observational health research.

Artificial intelligence programs outperformed doctors at answering typical patient questions — suggesting they could be used to write first-draft responses and help speed doctors’ work.

Vanderbilt researchers have identified cancer cell-specific genetic alterations that reprogram the immune “landscape,” thereby driving tumor growth, and discovered a potential new drug target for stopping it.